Related Experiment Video
Updated: Aug 10, 2026

Experimental Protocol for Using Drosophila As an Invertebrate Model System for Toxicity Testing in the Laboratory
Published on: July 10, 2018
Lead poisoning in children
1Department of Pediatrics, Milton S. Hershey Medical Center, Pannsylvania State University College of Medicine, Harshey 17033-0850, USA.
Insights
Pediatric lead exposure is a persistent issue. Meso 2,3-dimercaptosuccinic acid (DMSA) shows promise for lowering blood lead levels in children, though environmental cleanup remains crucial.
Area of Science:
- Environmental Health
- Pediatric Toxicology
- Public Health
Background:
- Childhood lead exposure and body burden remain significant public health concerns in the U.S.
- Widespread blood lead screening identifies many at-risk children, but screening criteria and age targets are debated.
- Lead screening has been less effective in certain populations, including rural areas and HMOs.
Purpose of the Study:
- To evaluate the effectiveness of meso 2,3-dimercaptosuccinic acid (DMSA) for treating lead exposure in children.
- To assess the efficacy of DMSA in lowering blood lead concentrations within specific ranges.
- To highlight the ongoing importance of environmental lead reduction strategies.
Main Methods:
- Review of evidence on DMSA efficacy for lead chelation in children.
- Analysis of blood lead concentration data in relation to DMSA treatment.
- Consideration of current treatment guidelines and limitations.
Main Results:
- DMSA is approved for oral chelation in children with blood lead levels above 45 µg/dL.
- Evidence suggests DMSA effectively lowers blood lead levels in children with concentrations between 25 and 45 µg/dL.
- The long-term effectiveness of chelation at lower lead levels requires further investigation.
Conclusions:
- Meso 2,3-dimercaptosuccinic acid (DMSA) offers a treatment option for children with elevated lead levels.
- Environmental decontamination remains the primary and most critical intervention for preventing and treating childhood lead exposure.
- Further research is needed to determine the long-term benefits of DMSA chelation at lower blood lead concentrations.
Abstract:
Increased lead exposure and increased body burden of lead remains a significant problem for children in the United States. With the increased use of blood level screening methods, a large percentage of children in many industrialized countries are being tested as a being at risk. A controversy continues over the definition of what population to screen and at what age to screen. There are parts of the United States, especially rural areas and health maintenance organization populations, where screening for lead exposure has not been productive. A new drug, DMSA (meso 2,3-dimercaptosuccinic acid) has been approved for oral chelation of children with increased body burden of lead. At the present time it is labeled for use in children with blood lead concentrations in excess of 45 micrograms/dL. Evidence exists that DMSA is effective in lowering the blood lead concentrations in children with levels between 25 and 45 micrograms/dL. The long-term effectiveness of chelation at lower levels is at present uncertain. There remains no substitution for strict environmental decontamination in the home environment of children and the workplace environment of their parents.
Related Concept Videos
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Prevention of Further Absorption of Poison
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical Poisoning: Treatment Strategies

